Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer

Radioactive-labelled ligands targeting the prostate-specific membrane antigen (PSMA), a transmembrane protein overexpressed in prostate cancer (PC), have shown promising activity in treatment of metastatic castration-resistant prostate cancer (mCRPC). PSMA-617 and PSMA-I&T (imaging and therapy),...

Descripción completa

Detalles Bibliográficos
Autores principales: Lunger, Lukas, Tauber, Robert, Feuerecker, Benedikt, Gschwend, Jürgen E., Eiber, Matthias, Heck, Matthias M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Management of Advanced Genitourinary Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575563/
https://www.ncbi.nlm.nih.gov/pubmed/34804839
http://dx.doi.org/10.21037/tau-20-1135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575563/
https://www.ncbi.nlm.nih.gov/pubmed/34804839
http://dx.doi.org/10.21037/tau-20-1135

Ejemplares similares